HUE068589T2 - Szepiapterin beadása táplálék nélkül szepiapterin-plazmaexpozíciót növelõ eljárásban való alkalmazásra - Google Patents

Szepiapterin beadása táplálék nélkül szepiapterin-plazmaexpozíciót növelõ eljárásban való alkalmazásra

Info

Publication number
HUE068589T2
HUE068589T2 HUE19811888A HUE19811888A HUE068589T2 HU E068589 T2 HUE068589 T2 HU E068589T2 HU E19811888 A HUE19811888 A HU E19811888A HU E19811888 A HUE19811888 A HU E19811888A HU E068589 T2 HUE068589 T2 HU E068589T2
Authority
HU
Hungary
Prior art keywords
sepiapterin
administration
food
increasing
plasma exposure
Prior art date
Application number
HUE19811888A
Other languages
English (en)
Hungarian (hu)
Inventor
Neil Smith
Jonathan Reis
Original Assignee
Ptc Therapeutics Mp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Mp Inc filed Critical Ptc Therapeutics Mp Inc
Publication of HUE068589T2 publication Critical patent/HUE068589T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HUE19811888A 2018-05-30 2019-05-30 Szepiapterin beadása táplálék nélkül szepiapterin-plazmaexpozíciót növelõ eljárásban való alkalmazásra HUE068589T2 (hu)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862677943P 2018-05-30 2018-05-30
US201862771398P 2018-11-26 2018-11-26
US201962822376P 2019-03-22 2019-03-22
GC201937663 2019-05-28

Publications (1)

Publication Number Publication Date
HUE068589T2 true HUE068589T2 (hu) 2025-01-28

Family

ID=68699037

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE19811888A HUE068589T2 (hu) 2018-05-30 2019-05-30 Szepiapterin beadása táplálék nélkül szepiapterin-plazmaexpozíciót növelõ eljárásban való alkalmazásra

Country Status (20)

Country Link
US (3) US11617752B2 (cg-RX-API-DMAC7.html)
EP (2) EP3801536B1 (cg-RX-API-DMAC7.html)
JP (2) JP7502197B2 (cg-RX-API-DMAC7.html)
CN (1) CN112703002A (cg-RX-API-DMAC7.html)
AU (2) AU2019277382B2 (cg-RX-API-DMAC7.html)
CA (1) CA3102106A1 (cg-RX-API-DMAC7.html)
DK (1) DK3801536T3 (cg-RX-API-DMAC7.html)
ES (1) ES2986920T3 (cg-RX-API-DMAC7.html)
FI (1) FI3801536T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241213T1 (cg-RX-API-DMAC7.html)
HU (1) HUE068589T2 (cg-RX-API-DMAC7.html)
LT (1) LT3801536T (cg-RX-API-DMAC7.html)
MD (1) MD3801536T2 (cg-RX-API-DMAC7.html)
MX (2) MX2020012979A (cg-RX-API-DMAC7.html)
PL (1) PL3801536T3 (cg-RX-API-DMAC7.html)
PT (1) PT3801536T (cg-RX-API-DMAC7.html)
RS (1) RS65874B1 (cg-RX-API-DMAC7.html)
SI (1) SI3801536T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400430T1 (cg-RX-API-DMAC7.html)
WO (1) WO2019232130A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
WO2018102315A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymoprhs of sepiapterin and salts thereof
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
CA3102105A1 (en) 2018-05-30 2019-12-05 Ptc Therapeutics Mp, Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
JP7778477B2 (ja) 2018-05-30 2025-12-02 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンの薬学的に許容される塩
JP7502197B2 (ja) 2018-05-30 2024-06-18 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリン血漿曝露を増加させるための方法
LT4009978T (lt) 2019-08-05 2024-11-25 Ptc Therapeutics Mp, Inc. Sepiapterino ir jo metabolitų panaudojimas spinduliuotės poveikio gydymui
CA3165636A1 (en) * 2020-01-24 2021-07-29 Neil Smith Methods for treating parkinson's disease with sepiapterin
WO2021168206A1 (en) * 2020-02-19 2021-08-26 Musc Foundation For Research Development L-sepiapterin and methods of use for treating diseases and disorders
US12691119B2 (en) 2021-02-09 2026-07-28 Ptc Therapeutics Mp, Inc. Methods for treating covid-19 with sepiapterin
IL305037A (en) * 2021-02-09 2023-10-01 Ptc Therapeutics Mp Inc Methods of treating glioblastomas with spiafatrin
CN120732846A (zh) * 2025-04-09 2025-10-03 中南大学湘雅医院 吲哚乙酸在制备预防或治疗高血压产品中的用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
US5910304A (en) 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
WO1997007236A1 (en) 1995-08-18 1997-02-27 Landry Donald W Detection of organic compounds through regulation of antibody-catalyzed reactions
US6036949A (en) 1998-03-05 2000-03-14 Amarillo Biosciences, Inc. Treatment of fibromyalgia with low doses of interferon
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
WO2005048926A2 (en) 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
CA2545968C (en) 2003-11-17 2010-03-09 Merck Eprova Ag Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride
PT3138566T (pt) 2003-11-17 2022-02-02 Biomarin Pharm Inc Tratamento de fenilcetonúria com bh4
JP5184783B2 (ja) 2003-11-17 2013-04-17 バイオマリン ファーマシューティカル インコーポレイテッド テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法
CN101132776A (zh) 2004-11-17 2008-02-27 生物马林药物股份有限公司 稳定的四氢生物喋呤片剂制剂
US20100130500A1 (en) 2004-12-08 2010-05-27 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
WO2006118322A1 (en) 2005-04-28 2006-11-09 Shiratori Pharmaceutical Co., Ltd. Method for producing hydrazone derivatives
US20080075666A1 (en) 2006-08-25 2008-03-27 Dudley Samuel C Jr Methods and compositions for treating diastolic dysfunction
KR20160065998A (ko) * 2007-04-11 2016-06-09 바이오마린 파머수티컬 인크. 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법
WO2010017570A2 (de) 2008-08-12 2010-02-18 Orpha Swiss Gmbh Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin
JP5066756B2 (ja) 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
CA2828685C (en) 2011-03-01 2018-05-29 Rubicon Research Private Limited Stable compositions of tetrahydrobiopterin
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
JP6084967B2 (ja) 2012-05-07 2017-02-22 白鳥製薬株式会社 セピアプテリン及びテトラヒドロラクトイルプテリンの製造法
EP3213062B1 (en) * 2014-10-31 2020-02-12 Children's Medical Center Corporation Methods and assays relating to sepiapterin reductase inhibition
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
WO2018102315A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymoprhs of sepiapterin and salts thereof
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
CN111328414B (zh) * 2017-11-23 2022-09-23 株式会社半导体能源研究所 显示装置及电子设备
JP7778477B2 (ja) 2018-05-30 2025-12-02 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンの薬学的に許容される塩
CA3102105A1 (en) * 2018-05-30 2019-12-05 Ptc Therapeutics Mp, Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
JP7502197B2 (ja) 2018-05-30 2024-06-18 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリン血漿曝露を増加させるための方法
LT4009978T (lt) 2019-08-05 2024-11-25 Ptc Therapeutics Mp, Inc. Sepiapterino ir jo metabolitų panaudojimas spinduliuotės poveikio gydymui
IL291565B1 (en) 2019-09-25 2026-04-01 Ptc Therapeutics Inc Method for treating phenylalanine irregularity

Also Published As

Publication number Publication date
EP3801536A1 (en) 2021-04-14
AU2019277382B2 (en) 2025-01-09
EP3801536A4 (en) 2022-03-23
US12329757B2 (en) 2025-06-17
JP2024069192A (ja) 2024-05-21
CN112703002A (zh) 2021-04-23
MX2020012979A (es) 2021-04-29
US20230381181A1 (en) 2023-11-30
DK3801536T3 (da) 2024-08-19
RS65874B1 (sr) 2024-09-30
AU2025200814A1 (en) 2025-02-27
EP3801536B1 (en) 2024-07-17
MD3801536T2 (ro) 2024-11-30
PL3801536T3 (pl) 2025-02-03
US20210220363A1 (en) 2021-07-22
JP2021525729A (ja) 2021-09-27
HRP20241213T1 (hr) 2024-11-22
US20260091037A1 (en) 2026-04-02
EP4454704A2 (en) 2024-10-30
FI3801536T3 (fi) 2024-08-29
ES2986920T3 (es) 2024-11-13
EP4454704A3 (en) 2025-01-01
JP7502197B2 (ja) 2024-06-18
MX2024005935A (es) 2024-06-04
PT3801536T (pt) 2024-09-19
JP7841005B2 (ja) 2026-04-06
LT3801536T (lt) 2024-09-25
WO2019232130A1 (en) 2019-12-05
SMT202400430T1 (it) 2024-11-15
AU2019277382A1 (en) 2021-01-21
CA3102106A1 (en) 2019-12-05
US11617752B2 (en) 2023-04-04
SI3801536T1 (sl) 2024-12-31

Similar Documents

Publication Publication Date Title
LT3801536T (lt) Sepiapterino vartojimas nevalgius, skirtas panaudoti taikant sepiapterino koncentracijos plazmoje padidinimo būdą
IL279632A (en) Compounds and Methods for Reducing LRRK2 Expression
IL284877B (en) Plasma-based coatings and methods for their preparation and use
IL279101A (en) Salts of spiafatrin are accepted in pharmacies
PL3043749T3 (pl) System i sposób podawania implantu do anuloplastyki
EP3522795A4 (en) METHOD AND DEVICE FOR STENT INSERTION
EP3272254A4 (en) Plasma non-stick pan and method for manufacturing same
HUE071511T2 (hu) Elafibranor primer biliáris cirrózis kezelésében történõ alkalmazásra
GB201516802D0 (en) Apparatus and method for determination of the dose of a powder inhalation formulation
PT3286166T (pt) Inibidores de replicação do vírus da imunodeficiência humana
EP2904905B8 (en) An apparatus for aligning and positioning pieces of food dough
SMT202100468T1 (it) 24-idrossisteroli sostituiti in posizione 11 per l'uso nel trattamento delle condizioni correlate all'nmda
EP3096763A4 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
PT3801534T (pt) Tratamento de fenilcetonúria com sepiapterina
EP3876307C0 (en) FILM PRODUCTION PROCESS
EP3145562A4 (en) Apparatus and method for the preparation and administration of blood components
GB2541049B (en) Method for forming multilayer coated film
PL3111929T3 (pl) Ulegający rozpadowi w jamie ustnej preparat w postaci błony zawierający tadalafil i sposób jego wytwarzania
GB2532606B (en) Multiple camera apparatus and method for synchronized autofocus
SG11201709707TA (en) Method for reducing the defectivity of a block copolymer film
EP3160521A4 (en) Sampling apparatus for determining the amount and uniformity of a delivered dose of drug related methods
ZA202204143B (en) Film and preparation method thereof
EP3198745A4 (en) Method and network node for facilitating timing synchronization in network
IL275486A (en) Formulation of a layer containing vardenafil, method for its preparation and use
GB201417597D0 (en) Film dispenser and method for manufacture thereof